Literature DB >> 22314554

Effects of patient movement on measurements of myocardial blood flow and viability in resting ¹⁵O-water PET studies.

Kazuhiro Koshino1, Hiroshi Watabe, Junichiro Enmi, Yoshiyuki Hirano, Tsutomu Zeniya, Shinji Hasegawa, Takuya Hayashi, Shigeru Miyagawa, Yoshiki Sawa, Jun Hatazawa, Hidehiro Iida.   

Abstract

BACKGROUND: Patient movement has been considered an important source of errors in cardiac PET. This study was aimed at evaluating the effects of such movement on myocardial blood flow (MBF) and perfusable tissue fraction (PTF) measurements in intravenous ¹⁵O-water PET.
METHODS: Nineteen ¹⁵O-water scans were performed on ten healthy volunteers and three patients with severe cardiac dysfunction under resting conditions. Motions of subjects during scans were estimated by monitoring locations of markers on their chests using an optical motion-tracking device. Each sinogram of the dynamic emission frames was corrected for subject motion. Variation of regional MBF and PTF with and without the motion corrections was evaluated.
RESULTS: In nine scans, motions during ¹⁵O-water scan (inter-frame (IF) motion) and misalignments relative to the transmission scan (inter-scan (IS) motion) larger than the spatial resolution of the PET scanner (4.0 mm) were both detected by the optical motion-tracking device. After correction for IF motions, MBF values changed from 0.845 ± 0.366 to 0.780 ± 0.360 mL/minute/g (P < .05). In four scans with only IS motion detected, PTF values changed significantly from 0.465 ± 0.118 to 0.504 ± 0.087 g/mL (P< .05), but no significant change was found in MBF values.
CONCLUSIONS: This study demonstrates that IF motion during ¹⁵O-water scan at rest can be source of error in MBF measurement. Furthermore, estimated MBF is less sensitive than PTF values to misalignment between transmission and ¹⁵O-water emission scans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314554      PMCID: PMC3358554          DOI: 10.1007/s12350-012-9522-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  21 in total

Review 1.  The perfusable tissue index: a marker of myocardial viability.

Authors:  Paul Knaapen; Ronald Boellaard; Marco J W Götte; Arno P van der Weerdt; Cees A Visser; Adriaan A Lammertsma; Frans C Visser
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

2.  Misalignment between PET transmission and emission scans: its effect on myocardial imaging.

Authors:  M E McCord; S L Bacharach; R O Bonow; V Dilsizian; A Cuocolo; N Freedman
Journal:  J Nucl Med       Date:  1992-06       Impact factor: 10.057

3.  A new strategy for the assessment of viable myocardium and regional myocardial blood flow using 15O-water and dynamic positron emission tomography.

Authors:  Y Yamamoto; R de Silva; C G Rhodes; L I Araujo; H Iida; E Rechavia; P Nihoyannopoulos; D Hackett; A R Galassi; C J Taylor
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

4.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.

Authors:  P Chareonthaitawee; P A Kaufmann; O Rimoldi; P G Camici
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

5.  Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect.

Authors:  H Iida; I Kanno; A Takahashi; S Miura; M Murakami; K Takahashi; Y Ono; F Shishido; A Inugami; N Tomura
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

6.  Preoperative prediction of the outcome of coronary revascularization using positron emission tomography.

Authors:  R de Silva; Y Yamamoto; C G Rhodes; H Iida; P Nihoyannopoulos; G J Davies; A A Lammertsma; T Jones; A Maseri
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

7.  Myocardial tissue fraction--correction for partial volume effects and measure of tissue viability.

Authors:  H Iida; C G Rhodes; R de Silva; Y Yamamoto; L I Araujo; A Maseri; T Jones
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

8.  Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography.

Authors:  H Iida; C G Rhodes; R de Silva; L I Araujo; P M Bloomfield; A A Lammertsma; T Jones
Journal:  J Nucl Med       Date:  1992-09       Impact factor: 10.057

9.  Three-dimensional registration of cardiac positron emission tomography attenuation scans.

Authors:  S L Bacharach; M A Douglas; R E Carson; P J Kalkowski; N M Freedman; P Perrone-Filardi; R O Bonow
Journal:  J Nucl Med       Date:  1993-02       Impact factor: 10.057

10.  Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy.

Authors:  Paul Knaapen; Ronald Boellaard; Marco J W Götte; Pieter A Dijkmans; Linda M C van Campen; Carel C de Cock; Gert Luurtsema; Cees A Visser; Adriaan A Lammertsma; Frans C Visser
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

View more
  13 in total

1.  Moving towards a better understanding of potential pitfalls in quantitative PET myocardial blood flow.

Authors:  Paul C Cremer; Frank P DiFilippo; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2017-02-22       Impact factor: 5.952

2.  Data-driven respiratory motion tracking and compensation in CZT cameras: a comprehensive analysis of phantom and human images.

Authors:  Chi-Lun Ko; Yen-Wen Wu; Mei-Fang Cheng; Ruoh-Fang Yen; Wen-Chau Wu; Kai-Yuan Tzen
Journal:  J Nucl Cardiol       Date:  2014-08-14       Impact factor: 5.952

3.  Motion detection and amelioration in a dedicated cardiac solid-state CZT SPECT device.

Authors:  John A Kennedy; H William Strauss
Journal:  Med Biol Eng Comput       Date:  2016-07-14       Impact factor: 2.602

Review 4.  Motion Correction and Its Impact on Absolute Myocardial Blood Flow Measures with PET.

Authors:  Marina Piccinelli; John R Votaw; Ernest V Garcia
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

5.  Blood pool and tissue phase patient motion effects on 82rubidium PET myocardial blood flow quantification.

Authors:  Edward P Ficaro; Venkatesh L Murthy; Benjamin C Lee; Jonathan B Moody; Alexis Poitrasson-Rivière; Amanda C Melvin; Richard L Weinberg; James R Corbett
Journal:  J Nucl Cardiol       Date:  2018-03-23       Impact factor: 5.952

Review 6.  Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence.

Authors:  Keiichiro Yoshinaga; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2015-04-22       Impact factor: 5.952

7.  Impact of pharmacological stress agent on patient motion during rubidium-82 myocardial perfusion PET/CT.

Authors:  Matthew J Memmott; Christine M Tonge; Kimberley J Saint; Parthiban Arumugam
Journal:  J Nucl Cardiol       Date:  2017-01-04       Impact factor: 5.952

8.  Optimizing accuracy and precision with motion correction of PET myocardial blood flow measurements.

Authors:  Alexis Poitrasson-Rivière; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2019-10-23       Impact factor: 5.952

9.  Automated dynamic motion correction using normalized gradient fields for 82rubidium PET myocardial blood flow quantification.

Authors:  Benjamin C Lee; Jonathan B Moody; Alexis Poitrasson-Rivière; Amanda C Melvin; Richard L Weinberg; James R Corbett; Venkatesh L Murthy; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2018-11-07       Impact factor: 5.952

10.  Cardiac 15O-water PET: Does mismatched attenuation correction not matter?

Authors:  Benjamin C Lee
Journal:  J Nucl Cardiol       Date:  2021-03-09       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.